Starting May 14th, 2021, the data in will be frozen in preparation for the migration to the new Primo VE-powered LocatorPlus Catalog which goes live June 8th, 2021. See the Technical Bulletin article for more information. will remain available until August 31st, 2021.

Start Over
Detailed View
SearchTitlesLibrary InformationOther DatabasesHelpHome

Collections of the National Library of Medicine
Search Request: Simple Search = 101744886
Search Results: Displaying 1 of 1 records

Summary ViewDetailed ViewTable of ContentsMARC ViewMore Like This

Demystifying medicine 2019. Sharon Savage, Marston Linehan.

Title: Demystifying medicine 2019. Inheritable cancer / Sharon Savage, Marston Linehan.
Variant Title: Inheritable cancer
Author(s)/Relationship(s): Savage, Sharon A. (Sharon Ann), speaker.
Linehan, Marston, speaker.
Publisher: [Bethesda, Md.] : [National Institutes of Health], [2019]
Related Names: National Institutes of Health (U.S.), issuing body.
Description: 1 online resource (1 streaming video file (1 hr., 51 min.)) : color, sound
Content Type: two-dimensional moving image
Media Type: computer
Carrier Type: online resource
Language: eng
Electronic Links:
MeSH Subjects: Neoplasms --genetics
Genetic Predisposition to Disease
Summary: (CIT): Cancer development often is a result of environmental factors, such as exposure to tobacco products and industrial toxins. Other times, however, cancer is written in the cards, nearly unavoidable, arising almost solely from genetic factors. These are so-called "inheritable cancers," and common types include cancers of the kidney, colon, and breast. Of course, what is inherited is a gene defect from a parent, not the cancer itself. Upwards of 10 percent of cancers may be the result of such inheritable mutations. For this next lecture in the Demystifying Medicine series, now fortified with CME, we bring you two speakers who are investigating inheritable cancers from a clinical and epidemiological perspective. Marston Linehan, chief of the NCI CCR Urologic Oncology Branch, pioneered the study of the genetic basis of kidney cancer. His team identified the genes for the common forms of kidney cancer and described the pathways of these kidney cancer genes. His recent studies targeting the metabolic basis of kidney cancer have resulted in the regression of metastatic cancer in patients with type 1 and type 2 papillary kidney cancer. Co-presenter Sharon Savage, DCEG Clinical Director and chief of the Clinical Genetics Branch, has studied the genetic and molecular epidemiology of telomere biology, pediatric cancer etiology, and autosomal-dominant cancer predisposition syndromes, such as Li-Fraumeni syndrome. She and her team are characterizing the clinical consequences of these disorders and are developing cancer screening programs.
Notes: Closed-captioned.
NLM Unique ID: 101744886
Other ID Numbers: (DNLM)CIT:27390


Options for Print, Save or E-mail
Select Download Format:
E-mail Full record(s) to:

SearchTitlesLibrary InformationOther DatabasesHelpHome

Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Contact NLM